» Authors » Mari Hamalainen

Mari Hamalainen

Explore the profile of Mari Hamalainen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 118
Citations 1393
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Loponen J, Vahatalo I, Tuomisto L, Niemela O, Lehtimaki L, Hamalainen M, et al.
J Asthma . 2024 Dec; :1-11. PMID: 39636329
Physical exercise in treatment of asthma is scarcely studied with no clear exercise guidelines for asthmatics. We aimed to investigate the associations between physical exercise frequency, systemic inflammation and asthma...
2.
Tavast I, Solismaa A, Lyytikainen L, Mononen N, Moilanen E, Hamalainen M, et al.
Acta Neuropsychiatr . 2024 Nov; :1-8. PMID: 39529327
Objective: Associations between leptin () and leptin receptor () gene polymorphisms and mood disorders have been found but not yet confirmed in multiple studies. The aim of our study was...
3.
Sallomy C, Awolade P, Rahnasto-Rilla M, Hamalainen M, Nousiainen L, Johansson N, et al.
ACS Med Chem Lett . 2024 Aug; 15(8):1221-1226. PMID: 39140042
Transient receptor potential ankyrin 1 (TRPA1) protein plays an important role in the inflammatory response, and it has been associated with different pain conditions and pain-related diseases, making TRPA1 a...
4.
Ryyti R, Hamalainen M, Tolonen T, Maki M, Jaakkola M, Peltola R, et al.
Nutrients . 2024 Jul; 16(13). PMID: 38999854
The percentage of obese people is increasing worldwide, causing versatile health problems. Obesity is connected to diseases such as diabetes and cardiovascular diseases, which are preceded by a state called...
5.
Maenpaa N, Tiainen L, Hamalainen M, Luukkaala T, Tanner M, Lahdenpera O, et al.
BMC Cancer . 2024 Mar; 24(1):331. PMID: 38468231
Background: Angiogenesis is crucial for tumor development, progression, and metastasizing. The most important regulator of angiogenesis is the vascular endothelial growth factor (VEGF) family, which is involved in multiple pathways...
6.
Lehtola T, Nummenmaa E, Nieminen R, Hamalainen M, Vuolteenaho K, Moilanen E
Basic Clin Pharmacol Toxicol . 2024 Mar; 134(5):686-694. PMID: 38439200
Glucocorticoids are widely used in the treatment of allergic and inflammatory diseases. Glucocorticoids have a widespread action on gene expression resulting in their pharmacological actions and also an array of...
7.
Kokko E, Choudhary M, Mutanen A, Honkonen M, Tikkakoski A, Koskela J, et al.
J Hypertens . 2024 Feb; 42(6):1057-1065. PMID: 38406920
Objectives: We examined haemodynamics, focusing on volume balance and forward and backward wave amplitudes, before and after 2.8 years of targeted treatment of primary aldosteronism. Patients with essential hypertension and...
8.
Luostarinen S, Hamalainen M, Pemmari A, Moilanen E
Inflamm Res . 2023 Jun; 72(7):1327-1339. PMID: 37386145
Background: Transient Receptor Potential Ankyrin 1 (TRPA1) is a cation channel that mediates pain, itch, cough, and neurogenic inflammation in response to pungent compounds such as acrolein in cigarette smoke....
9.
Halonen L, Pemmari A, Nummenmaa E, Hamalainen M, Moilanen T, Vuolteenaho K, et al.
Int J Mol Sci . 2023 Jun; 24(12). PMID: 37373205
Transient receptor potential (TRP) ion channels are expressed in neuronal and some non-neuronal cells and are involved particularly in pain and thermosensation. We previously showed that TRPA1 is functionally expressed...
10.
Taurio J, Hautaniemi E, Koskela J, Eraranta A, Hamalainen M, Tikkakoski A, et al.
BMC Cardiovasc Disord . 2023 Mar; 23(1):161. PMID: 36973671
Background: Obesity-related hypertension and the associated metabolic abnormalities are considered as a distinct hypertensive phenotype. Here we examined how abdominal fat content, as judged by waist:height ratio, influenced blood pressure...